News

Our Healthcare News

Centers for Medicare/Medicaid Services Establishes Coding and Payment for Eustachian Tube Balloon

PLYMOUTH, Minnesota—Entellus Medical, Inc. (NASDAQ: ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive…  

May 22 2017

Revance Announces Positive Results in RT002 Injectable Phase 2 Cervical Dystonia Trial

NEWARK, Calif.——Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in treating aesthetic and therapeutic conditions, today announced duration of effect…  

May 18 2017

Endologix Provides an Update on the Nellix Endovascular Aneurysm Sealing System US Regulatory Status

IRVINE, California – Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that the Company met with the…  

May 17 2017

EUSA Pharma and Apeiron Biologics Receive Positive CHMP Opinion for Dinutuximab Beta

HEMEL HEMPSTEAD, England and VIENNA, Austria – – EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, and…  

Mar 27 2017

Xenex Secures $38 Million in Funding Led by Essex Woodlands & Piper Jaffray Merchant Banking

SAN ANTONIO, Texas—Xenex Disinfection Services, the manufacturer of LightStrike Germ-Zapping Robots™, today announced the investment of $38 million in a funding round led by Essex…  

Feb 24 2017

Health Care Innovations are Coming to Your Digital Device

The Wall Street Journal - Opinion/Commentary

By Regina Benjamin and Adnrew Theompson

Mobile phones and tablets have pushed themselves to the center of modern life.…  

Feb 20 2017

Endologix Completes Patient Enrollment in the Ovation LUCY Study

IRVINE, California (GLOBE NEWSWIRE)—Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the…  

Feb 14 2017

Prolacta Bioscience Raises $35 Million in Mezzanine Financing

CITY OF INDUSTRY, California – Prolacta Bioscience®, the nation’s leading provider of human milk-based neonatal nutritional products, today announced the closing of a $35 million…  

Dec 06 2016

Metabolon Raises Additional $15 Million in Funding from Essex Woodlands

RESEARCH TRIANGLE PARK, N.C. – – Metabolon, Inc., the global leader in metabolomics, announced today that it has raised an additional $15 million in funding…  

Dec 05 2016